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Abstract It is widely accepted that heterochromatin is
necessary to maintain genomic stability. However,
direct experimental evidence supporting this is slim.
Previous studies using either enzyme inhibitors, gene
knockout or knockdown studies all are subject to the
caveat that drugs may have off-target effects and
enzymes that modify chromatin proteins to support
heterochromatin formation may also have numerous
other cellular targets as well. Here, we describe
PREditOR (protein reading and editing of residues), a
synthetic biology approach that allows us to directly
remove heterochromatin from cells without either drugs
or global interference with gene function. We find that
removal of heterochromatin perturbs mitotic progres-
sion and causes a dramatic increase in chromosome
segregation defects, possibly as a result of interfering
with the normal centromeric localization of the chromo-
somal passenger complex.
Keywords Heterochromatin . Chromosome
segregation . Centromeres . Mitosis
Introduction
Eukaryotic genomes are organized as a spectrum of
global chromatin states with differing epigenetic pro-
files. The first of these to be identified in interphase
nuclei as regions of compacted and decompacted chro-
matin were termed heterochromatin and euchromatin
(Bannister and Kouzarides 2011). Heterochromatin is a
transcriptionally repressive chromatin state that can be
either facultative or constitutive (Oberdoerffer and
Sinclair 2007). The former is a transient epigenetic state
found at promoters that changes in response to the
environment and during development to establish
tissue-specific gene expression and differentiation. Con-
stitutive heterochromatin remains compacted perma-
nently throughout cell differentiation and in different
cell types. Most constitutive heterochromatin is found
at pericentromeric regions, although it can also be found
at other sites, including telomeres (Saksouk et al. 2015)
and the long arm of the Y chromosome in mammals.
Centromeres, defined cytologically as the primary
constriction of mitotic chromosomes, are the loci that
direct chromosome segregation during cell division
(Fukagawa and Earnshaw 2014). Human centromeres
contain long stretches of non-coding alpha-satellite
DNA organized in high-order repeats (Aldrup-Macdon-
ald and Sullivan 2014). Centromeres can be divided into
two major compartments, the core centromere of
Bcentrochromatin^ (Sullivan and Karpen 2004) and the
pericentromere. Centrochromatin nucleates the assem-
bly of the kinetochore, a multi-protein complex that
binds microtubules and directs chromosome segregation
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(Fukagawa and Earnshaw 2014). Centrochromatin is
characterized by the presence of nucleosomes contain-
ing the centromere-specific histone H3 CENP-A
(Earnshaw and Migeon 1985) interspersed with nucle-
osomes containing canonical histone H3 bearing epige-
netic modifications associated with transcriptionally
active chromatin, such as H3K4me2 and H3K36me2
(Sullivan and Karpen 2004; Bergmann et al. 2011;
Fukagawa and Earnshaw 2014). Centrochromatin is
flanked by pericentromeric heterochromatin distin-
guished by the presence of characteristic histone modi-
fications, including histone H3 trimethylated on lysine 9
(H3K9me3), which binds heterochromatin protein 1
(HP1) and histone H4 trimethylated on lysine 20
(H4K20me3) (Allshire et al. 1995; Ekwall et al. 1995;
Bannister et al. 2001).
Diverse functional roles have been attributed to
pericentromeric heterochromatin. These include facili-
tating sister chromatid cohesion by recruiting and
retaining cohesin complexes in metaphase (Bernard
et al. 2001; Nonaka et al. 2002; Yamagishi et al. 2008;
Gartenberg 2009), suppressing inappropriate homolo-
gous recombination between repetitive DNA elements
(Peng and Karpen 2007) and kinetochore maintenance.
Indeed, euchromatin-heterochromatin boundaries have
been suggested to be preferred sites for kinetochore
formation in yeast and Drosophila melanogaster
(Folco et al. 2008; Olszak et al. 2011).
Despite disagreements regarding its functions
(Bernard et al. 2001; Koch et al. 2008), the importance
of proper regulation andmaintenance of pericentromeric
heterochromatin is suggested by the finding that knock-
out mice for the H3K9-specific methyltransferase
Suv39h1 show increased chromosomal instability
(CIN), embryonic lethality and are prone to tumour
formation (Peters et al. 2001). Furthermore, cancer cells
with lower levels of pericentromeric heterochromatin
show CIN (Slee et al. 2012). However, the precise role
of heterochromatin in regulating proper chromosome
segregation remains unclear.
Epigenetic regulation of chromatin can be
described as a series of consecutive steps in which
an EDITOR (writer or eraser) makes or removes a MARK
on a chromatin protein. A READER can either recog-
nize this MARK or cease to do so if the mark is
removed. The binding of the READER establishes a
CHROMATIN STATE, such as euchromatin, heterochroma-
tin or centrochromatin. We refer to this as an E →
M → R → C pathway. Here, we present a novel
synthetic biology approach called PREditOR (protein
reading and editing of residues) to dissect and manip-
ulate E → M → R → C pathways and analyse their
functional outcome.
In order to study the role(s) of heterochromatin on
chromosome segregation, we designed a PREditOR
strategy that allows us to remove heterochromatin with-
out drug treatments or global protein knockdowns. Our
studies reveal that heterochromatin removal from
pericentromeric regions leads to chromosome segrega-
tion defects as a result of disruption of kinetochore
structure, chromosome passenger complex delocaliza-
tion and decreases in centromeric stiffness during
mitosis.
Material and methods
Expression constructs
The SUV39H1ΔSET-EYFP constructs were obtained
as follows. The chromodomain of SUV39H1 was
amplified from a custommade cDNA library fromHeLa
cells and cloned into the NheI and AgeI restriction sites
of the pYIP-EYFP vector (Bergmann et al., 2011) gen-
erating SUV39H1ΔSET-EYFP, which contains 3′ attL
and attR sites for Gateway cloning (Fisher Technolo-
gies). Full length JMJD2Dwas PCR amplified from our
cDNA library using the oligonucleotides JMJD-Fw (5′-
caccatggaaactatgaagtc −3 ′) and JMJD-Rv (5 ′-
ttaaacgggcacagg-3′). The PCR product was used for
gateway cloning following the manufacturer’s instruc-
tions (Fisher Technologies), to generate the construct
pYIP-SUV39H1ΔSET-EYFP-JMJD2DWT, which
express this fusion protein from a CMV promoter and
confers resistance to puromycin. To generate the D195A
Fig. 1 Tethering JMJD2D to heterochromatin decrease
H3K9me3 levels. a Schematic of the PREdiTOR approach to
tether chromatin modifiers to heterochromatin regions. b
Schematic drawings of the SUV39H1ΔSET-EYFP fusion
constructs. c Diagram of the experimental design. d
Representative immunofluorescence images of HeLa cells
expressing the indicated SUV39H1ΔSET-EYFP fusion proteins
and stained for H3K9me3. Scale bar 10 μm. e Quantification of
fluorescence signals of H3K9me3 staining in individual
transfected cells as in d plotted as arbitrary fluorescence units
(A.F.U). Solid bars indicate the medians of three independent
experiments and error bars represent the standard error of the
mean (s.e.m). Asterisks indicate statistical significant differences
compared to EYFP (*P < 0.05; **P < 0.001; Student’s t test)
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mutant of JMJD2D and the W64AY67A double mutant
of SUV39H1ΔSET, the pYIP- SUV39H1ΔSET-EYFP-
JMJD2DWT construct was subjected to site-directed
mutagenesis using the QuikChange II kit (Stratagene).
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Cell culture, transfections and drug treatments
HeLa cells were maintained in DMEM supplemented
with 5% FBS (Invitrogen), 100 U/ml penicillin G and
100μg/ml streptomycin sulphate (Invitrogen). Cells were
grown at 37 °C in 5% CO2 in a humidified atmosphere.
Transfections were performed using Xtremegene-9
(Roche) following the manufacturer’s instructions. In
brief, for transfections of cells growing in 24-well plates
on polylysine-coated glass coverslips, transfection
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complexes containing 3 μl Xtremegene-9 reagent and
1 μg plasmid DNA were prepared in 100 μl OptiMEM
(Invitrogen). After 20 min of incubation at room temper-
ature, 25 μl of transfection complexes was added drop-
wise in each well. After 24 h, transfected cells were
selected adding 2 μg/ml of Puromycin (Sigma) and
grown for 24 additional hours before fixation.
For RNAi treatments, HeLa cell transfections were
performed using Polyplus jetPRIME (PEQLAB, South-
ampton, UK) with the indicated amounts of siRNA
oligos and 500 ng of plasmid DNA. After 24 h, fresh
DMEM was added and cells were maintained for 24
additional hours before fixation.
Indirect immunofluorescence and microscopy
Indirect immunofluorescence staining of cells fixed in 2.6
to 4% Formaldehyde/1xPBS was performed following
standard procedures. The following antibodies were used:
rabbit anti-H3K9me3 (abcam ab8898, 3% formaldehyde,
1/500), mouse anti-HP1α (Millipore MAB3584, 2.6%
Formaldehyde, 1/1000), rabbit anti-CENP-C (R554,
2.6% formaldehyde, 1/500), rabbit anti-CENP-B
(WCEB4, 2.6% formaldehyde, 1/500), mouse anti-
HEC1 (abcam AC3612, 2.6% formaldehyde, 1/1000),
mouse anti-Tubulin (Sigma B516, 1/2000), rabbit anti-
SGO1 (A. Losada, 4% formaldehyde, 1/1000), rabbit
anti-SMC2 (A. Losada, 4% formaldehyde, 1/1000), rab-
bit anti-Pericentrin (abcam AB4448; 4% formaldehyde,
1/500), rabbit anti-Survivin (Cell Signalling, 4% formal-
dehyde, 1/400) and rabbit anti-INCENP (Cell Signalling
P240, 4% formaldehyde, 1/500). Fluorophore-conjugated
secondary antibodies were purchased from Jackson Labs.
Microscope images were acquired on a DeltaVision
Core system (Applied Precision) using an inverted
Olympus IX-71 stand, with an Olympus UPlanSApo
×100 oil immersion objective (numerical aperture
(NA) 1.4) and a LED light source. Camera (Photomet-
rics Cool Snap HQ), shutter and stage were controlled
through SoftWorx (Applied Precision). Z-series were
collected with a spacing of 0.2 μm, and image stacks
were subsequently deconvolved in SoftWorx. Immuno-
fluorescence signals in deconvolved images were
analysed using ImageJ software (National Institutes of
Health, Bethesda,MD). For HEC1 signal quantification,
a custom-made macro in ImageJ modified from (Bodor
et al. 2014) was used. Intercentromeric distances were
measured with ImageJ using multiple z-stack images.
The distances between individual kinetochore pairs that
were clearly identified in individual z-stacks were
measured.
Immunoblotting analysis
Whole-cell extracts were prepared from HeLa cells
transfected with control siRNA, SMC2 siRNA and the
indicated vector DNAs. Immunoblotting analysis was
performed using the following primary antibodies:
rabbit anti-SMC (WCE 1:500) and mouse anti-Tubulin
(Sigma B512, 1:10,000). For protein detection and
quantification, we used donkey anti-mouse and anti-
rabbit fluorescence secondary antibodies (LI-COR
Bioscience 1:10,000).
Results
PREditOR (protein reading and editing of residues)
effectively removes heterochromatin
from pericentromeric regions
To manipulate the epigenetic status of defined chroma-
tin classes, we designed a novel synthetic biology
Fig. 2 Heterochromatin removal disrupts mitosis and
chromosome segregation. a Analysis of the frequency of mitotic
cells after expressing the indicated SUV39H1ΔSET-EYFP fusion
proteins. Data represent the mean and standard error of the mean
(s.e.m) of five independent experiments. b Analysis of the
frequency of every individual mitotic phase in relation of the
total number of mitoses. Data represents the mean and the
standard error of the mean (s.e.m) of six independent
experiments. c Representative IF images showing mitotic
abnormalities in HeLa cells. Images show examples of
chromosome bridges (top), lagging chromosomes (middle) and
uncongressed chromosomes (bottom). d Analysis of the
frequency of abnormal mitoses after expressing the indicated
SUV39H1ΔSET-EYFP fusion proteins. Data represent the mean
and standard error of the mean (s.e.m) of four independent
experiments. e Analysis of the frequency of mitotic cells
showing bridges or lagging chromosomes after expression of the
indicated SUV39H1ΔSET-EYFP fusion proteins. Data represent
the mean and standard error of the mean (s.e.m) of four
independent experiments. f Representative IF images showing
interphase abnormalities in HeLa cells. Images show a cell with
micronucleus (top), and a binucleate cell (bottom). g
Quantification of interphase abnormalities after expressing the
indicated SUV39H1ΔSET-EYFP fusion proteins. Data represent
the mean and standard error of the mean (s.e.m) of three
independent experiments. Asterisks indicate statistical significant
differences compared to EYFP (*P < 0.05, **P < 0.01,
***P < 0.001; Student’s t test)
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approach that allows us to tether chromatin EDITORS to
specific regions of the genome, protein reading and
editing of residues (PREditOR). PREditOR is based on
the use of fusion proteins consisting of three domains
(Supplementary Figure 1a): (i) a READER domain that
recognizes specific epigenetic modifications, (ii) a fluo-
rescent marker to follow the localization of the fusion
protein and (iii) a chromatin EDITOR that functions spe-
cifically at or near the tethering site. In order to analyse
the role of pericetromeric heterochromatin on chromo-
some segregation, we fused the N-terminal
chromodomain of H3K9-specific methyltransferase
SUV39H1 (SUV39H1ΔSET) (a READER of H3K9me3)
to an EYFP marker (Fig. 1a, b). Removal of the SET
domain ensures that this molecule functions solely as a
READER and not as an enzymatically active EDITOR.
Immunofluorescence analysis after expression of the
SUV39H1ΔSET-EYFP fusion protein in HeLa cells
showed colocalization with H3K9me3 and CENP-B
foci (Fig. 1d and Supplementary Figure 1b). Thus, this
fusion protein targets specifically to pericentromeric
heterochromatin. SUV39H1ΔSET-EYFP is released
from chromatin in early mitosis and rebinds later in
anaphase (Supplementary Figure 1c). This is most likely
due to a methyl/phos switch effect caused by phosphor-
ylation of histone H3 on Serine 10 catalysed by Aurora
B kinase (Fischle et al. 2005; Hirota et al. 2005).
As an EDITOR to remove H3K9me3 from
pericentromeric regions, we fused SUV39H1ΔSET-
EYFP to the H3K9me3-specific demethylase
JMJD2D /KDM4 (SUV39H1ΔSET-EYFP -
JMJD2DWT) (Fig. 1b, c). Two control molecules were
also constructed (Fig. 1b, c). The first was a catalytically
deadmutant of JMJD2D carrying a mutation in its jmjC-
enzymatic domain fused to SUV39H1ΔSET-EYFP
(SUV39H1ΔSET-EYFP-JMJD2DD195A). This mole-
cule targets to heterochromatin but cannot demethylate
H3K9. The second was a binding-deficient mutant of
SUV39H1ΔSET bearing two mutations of its
chromatin-binding domain fused to wild type JMJD2D
(SUV39H1ΔSETW61AY67A-EYFP-JMJD2DWT). This
molecule has an active demethylase but cannot target
specifically to heterochromatin.
Transient expression of SUV39H1ΔSET-EYFP-
JMJD2DWT in HeLa cells for 48 h efficiently removed
H3K9me3 from pericentromeric loci. Immunofluores-
cence analysis revealed significantly decreased levels of
H3K9me3 levels in cells expressing SUV39H1ΔSET-
EYFP-JMJD2DWT compared to the transfection and
tethering controls (EYFP and SUV39H1ΔSET-EYFP,
respectively) (Fig. 1d, e). Importantly, no differences in
H3K9me3 levels were observed after expressing either
the catalytically dead mutant (SUV39H1ΔSET-EYFP-
JMJD2DD195A) or the binding-deficient mutant
(SUV39H1ΔSETW61AY67A-EYFP-JMJD2DWT)
(Fig. 1d, e). Apparently, JMJD2D only efficiently
demethylates H3K9me3 when it is tethered to hetero-
chromatic regions. Consistent with these results,
immunofluorescence staining for HP1α, another
hallmark of heterochromatin, revealed a strongly signif-
icant decrease in HP1α foci in cells expressing
SUV39H1ΔSET-EYFP-JMJD2DWT compared with
cells expressing the other control constructs
(Supplementary Figure 1d and e).
We also investigated whether chromosomes overall
looked more decondensed after expression of
SUV39H1ΔSET-EYFP-JMJD2DWT fusion protein.
Although there did appear to be some slight
decompaction in live images, when chromosomes were
fixed and spreads prepared, no significant differences
were seen.
We conclude that PREditOR can effectively remove
H3K9me3 and specifically disrupt heterochromatin,
releasing downstream heterochromatin READERS such
as HP1α. Importantly, JMJD2D only removes hetero-
chromatin when it is tethered to the pericentromeric
regions of chromosomes.
Heterochromatin removal causes a mitotic accumulation
and chromosome segregation defects
To analyse the effects of heterochromatin removal on
ce l l d iv i s i on , we exp res s ed the d i f f e r en t
SUV39H1ΔSET-EYFP fusion proteins in HeLa cells
for 48 h and examined their effects on mitosis. Our
results show a threefold increase in the mitotic index
of cells expressing SUV39H1ΔSET-EYFP-JMJD2DWT
compared to cells expressing the control fusion proteins
(Fig. 2a). The control results demonstrate that
SUV39H1ΔSET-EYFP binding to pericentromeric
regions does not interfere with mitotic progression and
that the increase in mitotic index is due to the
demethylase activity of JMJD2D.
We observed significantly decreased levels of pro-
phase, metaphase and anaphase cells expressing
SUV39H1ΔSET-EYFP-JMJD2DWT compared to con-
trols (Fig. 2b). No difference was observed in the
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frequency of cells in telophase, though a small increase
was seen for cells in cytokinesis.
In order to analyse the effects of heterochromatin
removal on chromosome segregation, we quantified the
frequencies of mitotic abnormalities in HeLa cells
expressing the different SUV39H1ΔSET-EYFP fusion
proteins. We quantified the frequencies of anaphase brid-
ges, lagging chromosomes, uncongressed chromosomes
in metaphase and malformed spindles. Overall, cells
expressing SUV39H1ΔSET-EYFP-JMJD2DWT showed
a significantly increased frequency of abnormal mitosis
compared to cells expressing the other vectors (40 vs 8–
15%, respectively) (Fig. 2c, d). In particular, we observed
significantly increased frequencies of lagging chromo-
somes and bridges in cells expressing SUV39H1ΔSET-
EYFP-JMJD2DWT (Fig. 2e). Although there was no
significant increase in multipolar spindles as judged by
pericentrin staining, we did see a high frequency of other
spindle malformations (Supplementary Figure 2). Con-
sistent with the increased frequencies of mitotic
abnormalities, we also observed significantly increased
frequencies of micronuclei, a sensitive reporter for chro-
mosome segregation defects, in interphase cells express-
ing SUV39H1ΔSET-EYFP-JMJD2DWT compared with
controls (13 vs 4–6%) (Fig. 2f, g).
These data suggest that heterochromatin is necessary
for correct chromosome segregation during mitosis and
that its removal interferes with mitotic progression and
chromosome segregation fidelity.
Perturbing heterochromatin leads to centromere defects
Centromeres direct the assembly the kinetochore, a
multi-protein complex that binds to microtubules and
directs chromosome segregation (Fukagawa and
Earnshaw 2014). However, some kinetochore proteins,
including the Mis12 complex, have been reported to
bind to the heterochromatin flanking the core
centrochromatin (Obuse et al. 2004). In view of the
chromosome segregation defects reported above, we
asked whether heterochromatin removal is associated
with kinetochore defects.
Immunofluorescence staining for the outer kineto-
chore protein HEC1 was performed after expression of
the different SUV39H1ΔSET-EYFP fusion proteins for
48 h (the time point at which we observed significant
defects on chromosome segregation). We observed mild
but significant decreases in levels of HEC1 in cells
expressing all of the SUV39H1ΔSET-EYFP vectors
compared to the transfection control (Fig. 3a, b). This
suggests that the binding of SUV39H1ΔSET-EYFP
alone has an effect on kinetochore structure.
Although all constructs showed statistically significant
decreased levels of HEC1 compared with cells expressing
EYFP, the greatest decreasewas observed in cells express-
ing SUV39H1ΔSET-EYFP-JMJD2DWT (−49%). Lesser
decreases were observed in cells expressing
SUV39H1ΔSET-EYFP (−36%), SUV39H1ΔSET-
E Y F P - J M J D 2 D D 1 9 5 A ( − 2 4 % ) a n d
SUV39H1ΔSETW61AY67A-EYFP-JMJD2DWT (−9%).
Therefore, perturbing heterochromatin has a deleterious
effect on kinetochore structure. The SUV39H1ΔSET
module may exert a dominant-negative effect by
competing with READERS that bind to H3K9me3. This is
consistent with the observation that the SUV39H1ΔSET
binding mutant exhibited the mildest phenotype.
Pericentromeric heterochromatin has been associated
with the maintenance of cohesin in metaphase (Nonaka
et al. 2002). After prophase, cohesin complexes are
removed from the chromosome arms, but are retained
at centromeres as a result of the activity of Shugoshin 1
(SGO1) (Losada et al. 2002). Given previous links
between heterochromatin and cohesin in S. pombe
(Nonaka et al. 2002), we analysed the localization of
SGO1 after expressing the different SUV39H1ΔSET-
EYFP fusion proteins in HeLa cells. In transfection
controls, SGO1 showed a clear centromeric localization
in 95% of the cells (Fig. 3c, d). Expression of the
different SUV39H1ΔSET-EYFP proteins resulted in
significant increases in the frequency of cells with
SGO1 dispersed on chromosome arms (Fig. 3c, d).
T h u s , SUV39H1ΔSET-EYFP b i n d i n g t o
pericentromeric heterochromatin perturbs SGO1 centro-
meric localization. As was the case for HEC1 staining,
cells expressing SUV39H1ΔSET-EYFP-JMJD2DWT
more frequently exhibited SGO1 localization defects
than did cells expressing other SUV39H1ΔSET-EYFP
controls (Fig. 3c, d).
We conclude that SUV39H1ΔSET-EYFP fusion pro-
teins binding to pericentromeres generate mild defects on
the kinetochore and SGO1. However, these defects are
consistently higher after removing heterochromatin.
Heterochromatin cooperates with condensin to maintain
centromeric stiffness
We and others previously showed that the condensin
complex is important for maintaining the rigidity of the
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centromere (Gerlich et al. 2006; Ribeiro et al. 2009;
Jaqaman et al. 2010). We hypothesized that condensin
might act by regulating the compliance of centromeric
heterochromatin (Ribeiro et al. 2009). To test the effect
of removing heterochromatin on centromere stiffness,
we expressed the various SUV39H1ΔSET-EYFP
fusion proteins in HeLa cells for 48 h and analysed the
distances between sister kinetochores on metaphase
Fig. 3 Heterochromatin removal leads to centromere defects. a
Representative immunofluorescence images of HeLa cells
expressing the indicated SUV39H1ΔSET-EYFP fusion proteins
and stained for HEC1. Scale bar 10 μm. b Quantification of
fluorescence signals of HEC1 staining in individual cells
transfected as in (a) plotted as arbitrary fluorescence units
(A.F.U). Solid bars indicate the medians of two independent
experiments and error bars represent the standard error of the
mean (s.e.m). c Representative immunofluorescence images
showing prometaphase cells with localized (top) or dispersed
(bottom) SGO1, using CENP-A as centromere marker. Scale bar
10 μm. d Analysis of the frequency of cells showing localized or
dispersed SGO1 staining after expressing the indicated
SUV39H1ΔSET-EYFP fusion proteins. Data represent the mean
and standard error of the mean (s.e.m) of three independent
experiments
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chromosomes.We observed a significant increase in this
distance after expressing SUV39H1ΔSET-EYFP-
JMJD2DWT compared with controls (Fig. 4a, b). This
supports the notion that pericentromeric heterochroma-
tin has a role in maintaining centromeric stiffness.
In order to investigate our hypothesis that there is an
interaction between condensin and heterochromatin in
maintaining centromeric stiffness, we partly depleted
SMC2 in HeLa cells using published siRNAs (Gerlich
et al. 2006). Western blot analysis showed a 61%
decrease in SMC2 levels after siRNA transfection
(Supplementary Figure 3a). This was confirmed by
immunofluorescence analysis, which showed a reduc-
tion of SMC2 levels on chromosomes compared with
the control siRNA (Supplementary Figure 3b).
Although 39% of the SMC2 remained in cells under
these conditions, we observed the characteristic pheno-
types of condensin-depleted cells, including dramatic
changes in chromosome morphology, increased fre-
quencies of lagging chromosomes and chromosome
bridges (Supplementary Figure 3b and c).
Once the conditions for SMC2 depletion with siRNA
were established, we analysed the intercentromeric
distances of metaphase chromosomes after expressing
either SUV39H1ΔSET-EYFP or SUV39H1ΔSET-
EYFP-JMJD2DWT in the presence or absence of
SMC2 depletion (Fig. 4c). Consistent with previous
results from our group (Ribeiro et al. 2009), we
observed a strong increase in intercentromeric distances
in cells depleted of SMC2 compared with those
transfected with the control siRNA (Fig. 4d, e). Strik-
ingly, our analysis showed further significant increases
of intercentromeric distances in cells expressing
SUV39H1ΔSET-EYFP-JMJD2DWT compared with
controls expressing SUV39H1ΔSET-EYFP. This addi-
tional effect upon removal of heterochromatin was seen
both in the presence and absence of SMC2 (Fig. 4d, e).
These results show that heterochromatin cooperates
with condensin to maintain centromeric stiffness. How-
ever, the additive nature of the observed effect suggests
that condensin and heterochromatin make at least partly
independent contributions.
Heterochromatin is essential for proper chromosome
passenger complex localization
The chromosome passenger complex (CPC) of
Survivin, INCENP, Borealin and its catalytic subunit
Aurora B Kinase localizes to different targets during
mitosis, where it regulates key mitotic events
(Carmena et al. 2012). In early mitosis, the CPC is
localized at inner centromeres, where it ensures that
kinetochore-microtubule attachments are correct and
regulates the spindle assembly checkpoint. During ana-
phase, it transfers to the midzone where it regulates the
completion of cytokinesis (Fig. 5a) (Carmena et al.
2012).
It has been reported that centromeric HP1 targets the
CPC to centromeres in early mitosis (Ainsztein et al.
1998; Liu et al. 2014). In order to study the role of
heterochromatin on CPC localization at centromeres,
we expressed the different SUV39H1ΔSET-EYFP
vectors in HeLa cells for 48 h and analysed the locali-
zation of the CPC by staining for Survivin (Fig. 5a, b).
In control cells expressing SUV39H1ΔSET-EYFP, the
CPC concentrates at centromeres during prometaphase
(Fig. 5a, c). Strikingly, our immunofluorescence analy-
sis of cells expressing SUV39H1ΔSET-EYFP-
JMJD2DWT showed an increased frequency of cells
with the CPC dispersed on the chromosome arms in
early mitosis (Fig. 5b, c). Moreover, we observed
defects in CPC transfer to the midzone in late mitosis
(Fig. 5a , b, bot tom panels) . Expression of
SUV39H1ΔSET-EYFP-JMJD2DWT led to an increased
frequency of cells in late mitosis in which the CPC
remained attached to chromosomes and failed to con-
centrate at the spindle midzone.
We conclude that heterochromatin is necessary for
efficient CPC localization at centromeres and also for its
transfer to the midzone in late mitosis.
Discussion
The ever-expanding panoply of histone modifications
function by influencing the overall structure of chroma-
tin and by regulating the binding of chromatin READERS
(Bannister and Kouzarides 2011). Epigenetics can be
thought of as functioning through EDITOR→ MARK→
READER → CHROMATIN STATE (E → M → R → C)
pathways that can be artificially engineered by our syn-
thetic biology approach PREditOR. Three examples
amongst the many READERS that bind to specific histone
modifications include the chromatin remodeller CHD1,
which binds to H3K4me2/3 (Sims et al. 2005), the
polycomb repressor complex subunit PRC1, which
binds to H3K27me3 (Cao et al. 2002; Levine et al.
2002) and the H3K9 methyltransferase SUV39H1,
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which binds to H3K9me2/3 (Rea et al. 2000). Our
PREditOR approach can be applied to study any of these
pathways as we have shown in several previous studies
focused on the epigenetic landscape of the centromere of
a synthetic human artificial chromosome (HAC –
(Nakano et al. 2008; Cardinale et al. 2009; Bergmann
et al. 2011; Martins et al. 2016; Molina et al., 2016).
Here, we describe the first use of PREditOR to study
native human chromosomes. We designed a specific
PREditOR strategy to tether an EDITOR to constitutive
heterochromatin regions as a fusion to the chromodomain
of the H3K9-specific methyltransferase SUV39H1 linked
to EYFP. It was previously reported that the truncated
SUV39H1 protein maintaining only its chromodomain
targets specifically to pericentromeric regions (Melcher
et al. 2000; Krouwels et al. 2005), which comprise the
bulk of constitutive heterochromatin in eukaryotic cells.
Consistent with those reports, we observed a strong
colocalization of SUV39H1ΔSET-EYFP with hetero-
chromatin foci containing the centromeric protein
CENP-B in HeLa cells. We also observed a similar
colocalization after expressing SUV39H1ΔSET-EYFP
in other human cell lines, including HT1080 and
RPE1hTERT (data not shown). Immunofluorescence
analysis staining for H3K9me3 and HP1α after express-
ing SUV39H1ΔSET-EYFP-JMJD2DWTshowed residual
diffuse antibody signals in all nuclei, but a loss of the
characteristic heterochromatin foci (Fig. 1d and
Supplementary Figure 1d). These results suggest that
SUV39H1ΔSET-EYFP express ion dis rup ts
pericentromeric heterochromatin.
Removal of heterochromatin leads to defects in
mitosis subsequent to delays in prometaphase.
Many of these may be explained by defects in
localization of the CPC observed after heterochro-
matin removal (Fig. 5). The CPC controls the
proper attachment of kinetochores to microtubules
and activates the spindle assembly checkpoint until
chromosomes are properly aligned (Carmena et al.,
2012).
Importantly, cells expressing several control
SUV39H1ΔSET-EYFP fusion proteins behaved like
the transfection control (EYFP alone). Thus,
SUV39H1ΔSET binding did not interfere with normal
mitotic progression. In contrast, other authors have
observed a mitotic arrest after inhibiting SUV39H1 by
its specific inhibitor chaetonin, which decreases the
levels of heterochromatin (Chu et al. 2014; Chu et al.
2012). This stronger phenotype could be due to off-
target effects of the drug or to the action of SUV39H1
on other targets required for mitotic progression.
Disruption of pericentromeric heterochromatin has
been reported to affect chromosome segregation and to
increase genomic instability in yeast (Ekwall et al.
1995), mice (Peters et al. 2001) and human cells (Slee
et al. 2012). Surprisingly, although double null mutants
for Suv39h1 and Suv39h2 in mice show severely
impaired viability, a low level of live offspring (33%)
was obtained. These double null or Suv39h1-null mice
showed an increased predisposition to B cell lympho-
mas with hyperdiploid karyotypes, suggesting that lack
of pericentromeric heterochromatin might increase
genomic instability by impairing chromosome segrega-
tion (Peters et al. 2001). Consistent with these results,
our data show a threefold increase on chromosome
segregation defects after removing heterochromatin by
expressing SUV39H1ΔSET-EYFP-JMJD2DWT in
human cells for 48 h. Since HeLa cells divide approxi-
mately once every 24 h, chromosome segregation
defects must occur in the first or at most the second
mitosis after heterochromatin removal.
Heterochromatin removal appeared to affect several
protein complexes that are important for centromere
function. Two of these effects were expected. First, we
observed that heterochromatin depletion causes an
increase in the compliance (stretchiness) of inner cen-
tromeres, with the result that the distance between sister
kinetochores is increased. This is consistent with previ-
ous suggestions that condensin regulates centromeric
Fig. 4 Heterochromatin is necessary to maintain the stiffness of
t h e c en t r ome r e i n me t a ph a s e . a Rep r e s e n t a t i v e
immunofluorescence images of HeLa cells expressing the
indicated SUV39H1ΔSET-EYFP fusion proteins and stained for
CENP-C and Tubulin. b Quantification of intercentromeric dis-
tances in chromosomes under tension after expressing the indicat-
ed SUV39H1ΔSET-EYFP fusion proteins. Data represent the
mean and standard error of the mean (s.e.m) of three independent
experiments. c Immunoblot of whole HeLa cell protein extract
transfected with the indicated siRNA and DNAs. Immunoblot for
SMC2 with Tubulin as a loading control. d Representative immu-
nofluorescence images of HeLa cells expressing the indicated
SUV39H1ΔSET-EYFP fusion proteins and transfected with the
indicated siRNA. eQuantification of intercentromeric distances in
chromosomes under tension after expressing the indicated
SUV39H1ΔSET-EYFP fusion proteins and siRNAs. Data repre-
sent the mean and standard error of the mean (s.e.m) of three
independent experiments. Asterisks indicate statistical significant
differences compared to EYFP (*P < 0.05, **P < 0.01,
***P < 0.001; Student’s t test)
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stiffness by regulating the compliance of centromeric
heterochromatin (Ribeiro et al. 2009; Jaqaman et al.
2010). It is not clear if this effect is due to changes in
the higher-order packing of the chromatin fibre or is
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Fig. 5 Heterochromatin removal disrupts chromosomal passenger
localization in mitosis. a, b Representative immunofluorescence
images of HeLa cells expressing SUV39H1ΔSET-EYFP (a) or
SUV39H1ΔSET-EYFP-JMJD2DWT (b) fusion protein and
stained for Survivin and Tubulin. Scale bar 10 μm. c Analysis of
the frequency of cells showing dispersed CPC in prometaphase
and metaphase after expressing the indicated SUV39H1ΔSET
fusion proteins. Data represent the mean and standard error of
the mean (s.e.m) of two independent experiments. Asterisks indi-
cate statistical significant differences compared to EYFP
(*P < 0.05, **P < 0.01; Student’s t test)
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mediated by centromeric cohesin complexes, as hetero-
chromatin removal resulted in SGO1 displacement,
which might result in lower levels of cohesin at the
centromere. The association of heterochromatin with
cohesin is currently a matter of debate (Bernard et al.
2001; Koch et al. 2008). Since SGO1 is involved in
cohesin complex maintenance at centromeres after pro-
phase until anaphase onset, our results suggest that
interfering with SGO1 targeting to centromeres caused
by heterochromatin removal might perturb sister chro-
matid cohesion.
We also observed that centromeric heterochromatin
is required for efficient localization of the chromosomal
passenger complex (CPC) to inner centromeres during
early mitosis. This could be predicted from results indi-
cating that binding to SGO1 (Yamagishi et al. 2010) and
to heterochromatin protein HP1α are both important for
targeting of the CPC in early mitosis. As stated above,
defects in CPC localization may explain many of the
mitotic defects observed following heterochromatin
removal.
Binding of SUV39H1ΔSET fusion proteins to
pericentromeric heterochromatin had a small, but repro-
ducible effect on assembly of the kinetochore. This was
not expected, because the kinetochore assembles on the
surface of CENP-A-containing centrochromatin and not
on the pericentromere. Indeed, in preliminary results, we
noticed an increase in the amount of CENP-A associated
with centromeres when heterochromatin was depleted.
This is consistent with previous results in which the Rb
pathway was perturbed, leading to a decrease in H3K9
methylation (Sullivan et al. 2011). SUV39H1 has a dual
role in heterochromatin formation and maintenance: it
acts as a methyltransferase and also has a structural role
at pericentromeric heterochromatin by binding HP1α
(Haldar et al. 2011). Overexpressed SUV39H1ΔSET
might affect kinetochore assembly either by perturbing
HP1α dynamics, or possibly as a result of its effects on
SGO1 or CPC localization.
The present results demonstrate the utility of the
PREditOR approach for epigenetic engineering—in this
case to specifically remove heterochromatin from divid-
ing cells. It had been widely assumed that heterochro-
matin would be important for mitotic chromosome seg-
regation, but previous studies were plagued by the pos-
sibility of off-target effects of drugs and genetic manip-
ulations. Here, we confirm that heterochromatin is
indeed important for mitotic chromosome segregation,
although the effects of heterochromatin removal on
pericentromeric heterochromatin structure, mitotic pro-
gression and on chromosome segregation are remark-
ably mild. We conclude that heterochromatin at centro-
meres is necessary to maintain genomic stability.
Acknowledgements We thank Nuno Martins for interesting
discussions that contributed to the development of the PREditOR
approach. O.M. was funded by the European Molecular Biology
Organization (long-term EMBO fellowship; ALTF-453-2012).
This work was funded by the Wellcome Trust, of which W.C.E.
is a Principal Research Fellow (grant number 073915). The
Wellcome Trust Centre for Cell Biology is supported by core grant
numbers 077707 and 092076.
Compliance with ethical standards
Conflict of Interest The authors declare that they have no
conflict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestrict-
ed use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons license, and indicate if
changes were made.
References
Ainsztein AM, Kandels-Lewis SE, Mackay AM, Earnshaw WC
(1998) INCENP centromere and spindle targeting: identifi-
cation of essential conserved motifs and involvement of
heterochromatin protein HP1. J Cell Biol 143:1763–1774
Aldrup-Macdonald ME, Sullivan BA (2014) The past, present,
and future of human centromere genomics. Genes 5:33–50
Allshire RC, Nimmo ER, Ekwall K, Javerzat JP, Cranston G
(1995) Mutations derepressing silent centromeric domains
in fission yeast disrupt chromosome segregation. Genes
Dev 9:218–233
Bannister AJ, Kouzarides T (2011) Regulation of chromatin by
histone modifications. Cell Res 21:381–395. doi:10.1038
/cr.2011.22
Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO,
Allshire RC, Kouzarides T (2001) Selective recognition of
methylated lysine 9 on histone H3 by the HP1 chromo
domain. Nature 410:120–124. doi:10.1038/35065138
Bergmann JH et al (2011) Epigenetic engineering shows
H3K4me2 is required for HJURP targeting and CENP-A
assembly on a synthetic human kinetochore. EMBO J 30:
328–340. doi:10.1038/emboj.2010.329
Bernard P, Maure JF, Partridge JF, Genier S, Javerzat JP, Allshire
RC (2001) Requirement of heterochromatin for cohesion at
centromeres. Science 294:2539–2542. doi:10.1126
/science.1064027
Bodor DL et al (2014) The quantitative architecture of centromeric
chromatin. eLife 3:e02137. doi:10.7554/eLife.02137
PREditOR: a synthetic biology approach 507
Cao R et al (2002) Role of histone H3 lysine 27 methylation in
polycomb-group silencing. Science 298:1039–1043.
doi:10.1126/science.1076997
Cardinale S et al (2009) Hierarchical inactivation of a synthetic
human kinetochore by a chromatin modifier. Mol Biol Cell
20:4194–4204. doi:10.1091/mbc.E09-06-0489
CarmenaM,WheelockM, Funabiki H, EarnshawWC (2012) The
chromosomal passenger complex (CPC): from easy rider to
the godfather of mitosis. Nat Rev Mol Cell Biol 13:789–803.
doi:10.1038/nrm3474
Chu L et al (2014) The spatiotemporal dynamics of chromatin
protein HP1alpha is essential for accurate chromosome seg-
regation during cell division. J Biol Chem 289:26249–26262.
doi:10.1074/jbc.M114.581504
Chu L et al (2012) SUV39H1 orchestrates temporal dynamics of
centromeric methylation essential for faithful chromosome
segregation in mitosis. J Mol Cell Biol 4:331–340.
doi:10.1093/jmcb/mjs023
Earnshaw WC, Migeon BR (1985) Three related centromere pro-
teins are absent from the inactive centromere of a stable
isodicentric chromosome. Chromosoma 92:290–296
Ekwall K, Javerzat JP, Lorentz A, Schmidt H, CranstonG, Allshire
R (1995) The chromodomain protein Swi6: a key component
at fission yeast centromeres. Science 269:1429–1431
Fischle W et al (2005) Regulation of HP1-chromatin binding by
histone H3 methylation and phosphorylation. Nature 438:
1116–1122. doi:10.1038/nature04219
Folco HD, Pidoux AL, Urano T, Allshire RC (2008)
Heterochromatin and RNAi are required to establish CENP-
A chromatin at centromeres. Science 319:94–97. doi:10.1126
/science.1150944
Fukagawa T, Earnshaw WC (2014) The centromere: chromatin
foundation for the kinetochore machinery. Dev Cell 30:496–
508. doi:10.1016/j.devcel.2014.08.016
Gartenberg M (2009) Heterochromatin and the cohesion of sister
chromatids. Chromosom Res 17:229–238. doi:10.1007
/s10577-008-9012-z
Gerlich D, Hirota T, Koch B, Peters JM, Ellenberg J (2006)
Condensin I stabilizes chromosomes mechanically through
a dynamic interaction in live cells. Curr Biol 16:333–344.
doi:10.1016/j.cub.2005.12.040
Haldar S, Saini A, Nanda JS, Saini S, Singh J (2011) Role of Swi6/
HP1 self-association-mediated recruitment of Clr4/Suv39 in
establishment and maintenance of heterochromatin in fission
yeast. J Biol Chem 286:9308–9320. doi:10.1074/jbc.
M110.143198
Hirota T, Lipp JJ, Toh BH, Peters JM (2005) Histone H3 serine 10
phosphorylation by Aurora B causes HP1 dissociation from
heterochromatin. Nature 438:1176–1180. doi:10.1038
/nature04254
Jaqaman K et al (2010) Kinetochore alignment within the meta-
phase plate is regulated by centromere stiffness and microtu-
bule depolymerases. J Cell Biol 188:665–679. doi:10.1083
/jcb.200909005
Koch B, Kueng S, Ruckenbauer C, Wendt KS, Peters JM (2008)
The Suv39h-HP1 histone methylation pathway is dispens-
able for enrichment and protection of cohesin at centromeres
in mammalian cells. Chromosoma 117:199–210.
doi:10.1007/s00412-007-0139-z
Krouwels IM,Wiesmeijer K, AbrahamTE,Molenaar C, Verwoerd
NP, Tanke HJ, Dirks RW (2005) A glue for heterochromatin
maintenance: stable SUV39H1 binding to heterochromatin is
reinforced by the SET domain. J Cell Biol 170:537–549.
doi:10.1083/jcb.200502154
Levine SS, Weiss A, Erdjument-Bromage H, Shao Z, Tempst P,
Kingston RE (2002) The core of the polycomb repressive
complex is compositionally and functionally conserved in
flies and humans. Mol Cell Biol 22:6070–6078
Liu X et al (2014) Chromatin protein HP1alpha interacts with the
mitotic regulator Borealin protein and specifies the centro-
mere localization of the chromosomal passenger complex. J
Biol Chem 289:20638–20649. doi :10.1074/jbc.
M114.572842
Losada A, Hirano M, Hirano T (2002) Cohesin release is required
for sister chromatid resolution, but not for condensin-
mediated compaction, at the onset of mitosis. Genes Dev
16:3004–3016. doi:10.1101/gad.249202
Martins NM, Bergmann JH, Shono N, Kimura H, Larionov V,
Masumoto H, Earnshaw WC (2016) Epigenetic engineering
shows that a human centromere resists silencing mediated by
H3K27me3/K9me3. Mol Biol Cell 27:177–196. doi:10.1091
/mbc.E15-08-0605
Melcher M, SchmidM, Aagaard L, Selenko P, Laible G, Jenuwein
T (2000) Structure-function analysis of SUV39H1 reveals a
dominant role in heterochromatin organization, chromosome
segregation, andmitotic progression.Mol Cell Biol 20:3728–
3741
Molina O, Vargiu G, Abad MA, Zhiteneva A, Jeyaprakash AA,
Masumoto H, Kouprina N, Larionov V, Earnshaw WC
(2016) Epigenetic engineering reveals a balance between
histone modifications and transcription in kinetochore main-
tenance. Nat Commun. doi:10.1038/ncomms13334
Nakano M et al (2008) Inactivation of a human kinetochore by
specific targeting of chromatin modifiers. Dev Cell 14:507–
522. doi:10.1016/j.devcel.2008.02.001
Nonaka N, Kitajima T, Yokobayashi S, Xiao G, Yamamoto M,
Grewal SI, Watanabe Y (2002) Recruitment of cohesin to
heterochromatic regions by Swi6/HP1 in fission yeast. Nat
Cell Biol 4:89–93. doi:10.1038/ncb739
Oberdoerffer P, Sinclair DA (2007) The role of nuclear architec-
ture in genomic instability and ageing. Nat RevMol Cell Biol
8:692–702. doi:10.1038/nrm2238
Obuse C, Iwasaki O, Kiyomitsu T, Goshima G, Toyoda Y,
Yanagida M (2004) A conserved Mis12 centromere complex
is linked to heterochromatic HP1 and outer kinetochore pro-
tein Zwint-1. Nat Cell Biol 6:1135–1141. doi:10.1038
/ncb1187
Olszak AM et al (2011) Heterochromatin boundaries are hotspots
for de novo kinetochore formation. Nat Cell Biol 13:799–
808. doi:10.1038/ncb2272
Peng JC, Karpen GH (2007) H3K9 methylation and RNA inter-
ference regulate nucleolar organization and repeated DNA
stability. Nat Cell Biol 9:25–35. doi:10.1038/ncb1514
Peters AH et al (2001) Loss of the Suv39h histone methyltrans-
ferases impairs mammalian heterochromatin and genome
stability. Cell 107:323–337
Rea S et al (2000) Regulation of chromatin structure by site-
specific histone H3 methyltransferases. Nature 406:593–
599. doi:10.1038/35020506
Ribeiro SA et al (2009) Condensin regulates the stiffness of
vertebrate centromeres. Mol Biol Cell 20:2371–2380.
doi:10.1091/mbc.E08-11-1127
508 Molina O. et al.
Saksouk N, Simboeck E, Dejardin J (2015) Constitutive hetero-
chromatin formation and transcription in mammals.
Epigenetics Chromatin 8:3. doi:10.1186/1756-8935-8-3
Sims RJ 3rd, Chen CF, Santos-Rosa H, Kouzarides T, Patel SS,
Reinberg D (2005)Human but not yeast CHD1 binds directly
and selectively to histone H3 methylated at lysine 4 via its
tandem chromodomains. J Biol Chem 280:41789–41792.
doi:10.1074/jbc.C500395200
Slee RB et al (2012) Cancer-associated alteration of pericentromeric
heterochromatin may contribute to chromosome instability.
Oncogene 31:3244–3253. doi:10.1038/onc.2011.502
Sullivan BA, Karpen GH (2004) Centromeric chromatin exhibits a
histone modification pattern that is distinct from both euchro-
matin and heterochromatin. Nat Struct Mol Biol 11:1076–
1083. doi:10.1038/nsmb845
Sullivan LL, Boivin CD, Mravinac B, Song IY, Sullivan BA
(2011) Genomic size of CENP-A domain is proportional to
total alpha satellite array size at human centromeres and
expands in cancer cells. Chromosome research: an interna-
tional journal on the molecular, supramolecular and evolu-
tionary aspects of chromosome biology 19:457–470.
doi:10.1007/s10577-011-9208-5
Yamagishi Y, Honda T, Tanno Y (2010) Watanabe Y. Two histone
marks establish the inner centromere and chromosome bi-
or ienta t ion Science 330:239–243. doi :10 .1126
/science.1194498
Yamagishi Y, Sakuno T, Shimura M (2008) Watanabe Y.
Heterochromatin links to centromeric protection by
recruiting shugoshin Nature 455:251–255. doi:10.1038
/nature07217
PREditOR: a synthetic biology approach 509
